Kindred Biosciences, Inc.

UEI
GQEBHPTLG7Y1
CAGE
6SYU9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
elanco.com
Founded
1954
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 -$279,101

Contract vehicles

No active vehicles.

1 expired vehicle

Contract awards

Award Agency Obligated Awarded
Cgmp RE-supply of HPV 16L1/16RG1 75N91021F00001 National Cancer Institute (NIH) $576,173

Quick answers

Is Kindred Biosciences, Inc. registered in SAM.gov?

Kindred Biosciences, Inc.'s SAM.gov registration expired on March 12, 2023.

Which contract vehicles does Kindred Biosciences, Inc. hold?

Kindred Biosciences, Inc. holds a place on 1 federal contract vehicle: PREVENT Cancer Preclinical Drug Development Program.

What is Kindred Biosciences, Inc.'s most recent federal award?

Kindred Biosciences, Inc.'s most recent federal contract award is Cgmp RE-supply of HPV 16L1/16RG1 (75N91021F00001), from National Cancer Institute (NIH), on February 26, 2021.

On GovTribe

See Kindred Biosciences, Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors